Table 2 Prevalence of febrile illnesses among pregnant women attending outpatient clinics
Patient characteristics | Frequency (%) |
|---|---|
Duration of current febrile episode (days) | N = 998 |
   1–6 days | 858 (86.0) |
   7–14 days | 140 (14.0) |
Malaria parasite prevalence | Â |
Negative | 870 (87.2) |
Positive | 128 (12.8) |
Treatment given to patients with confirmed malaria | N = 128 |
Coartem | 72 (56.3) |
Fansidar (SP) | 14 (10.9) |
Quinine | 33 (25.8 ) |
Paracetamol | 1 (0.8) |
Antibiotic | 8 (6.2) |
Treatment of non-malarial fevers | N = 870 |
Chloroquine | 45 (5.2 ) |
Coartem | 186 (21.4) |
Fansidar (SP) | 423 (48.6) |
Quinine | 32 (3.7 ) |
Paracetamol | 52 (6.0) |
Antibiotic | 113 (13.0) |
Cotrimoxazole | 19 (2.1) |
Appropriate treatment of malaria | Â |
Parasite positive patients who received Coartem + parasite negative patients who received no antimalarial drug/total number of febrile cases | 35.5% |
Malaria treatment and preventive practices | N = 998 |
Proportion of patients who had taken an anti-malaria drug before this visit | 313 (31.4) |
Proportion of patients who slept under a net the previous night | 909 (91.1) |
Proportion of patients who sleep under a net every day | 892 (89.4) |